NG-Nitroarginine Methyl Ester
"NG-Nitroarginine Methyl Ester" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
| Descriptor ID |
D019331
|
| MeSH Number(s) |
D12.125.068.050.525 D12.125.095.104.525
|
| Concept/Terms |
NG-Nitroarginine Methyl Ester- NG-Nitroarginine Methyl Ester
- Methyl Ester, NG-Nitroarginine
- NG Nitroarginine Methyl Ester
- N omega-Nitro-L-arginine Methyl Ester
- N omega Nitro L arginine Methyl Ester
- NG-Nitro-L-Arginine Methyl Ester
- Methyl Ester, NG-Nitro-L-Arginine
- NG Nitro L Arginine Methyl Ester
- N(G)-Nitroarginine Methyl Ester
- N(omega)-Nitro-L-arginine Methyl Ester
- L-NAME
- N(G)-Nitro-L-arginine Methyl Ester
|
Below are MeSH descriptors whose meaning is more general than "NG-Nitroarginine Methyl Ester".
Below are MeSH descriptors whose meaning is more specific than "NG-Nitroarginine Methyl Ester".
This graph shows the total number of publications written about "NG-Nitroarginine Methyl Ester" by people in this website by year, and whether "NG-Nitroarginine Methyl Ester" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 3 | 3 |
| 1996 | 1 | 4 | 5 |
| 1997 | 1 | 6 | 7 |
| 1998 | 0 | 3 | 3 |
| 1999 | 2 | 4 | 6 |
| 2000 | 1 | 3 | 4 |
| 2001 | 0 | 4 | 4 |
| 2002 | 4 | 2 | 6 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 4 | 4 |
| 2008 | 1 | 2 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NG-Nitroarginine Methyl Ester" by people in Profiles.
-
Calcium-mediated oxidative stress: a common mechanism in tight junction disruption by different types of cellular stress. Biochem J. 2017 02 20; 474(5):731-749.
-
NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil. Oncotarget. 2016 Jul 26; 7(30):47576-47585.
-
Endothelium-dependent relaxations in the aorta from K(2p)6.1 knockout mice. Am J Physiol Regul Integr Comp Physiol. 2013 Jul 01; 305(1):R60-7.
-
Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon. Int J Cardiol. 2013 Sep 10; 167(6):3000-5.
-
Hypobaric intermittent hypoxia attenuates hypoxia-induced depressor response. PLoS One. 2012; 7(7):e41656.
-
Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2012 Jan 01; 302(1):F47-51.
-
Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats. Am J Obstet Gynecol. 2011 Jul; 205(1):83.e1-7.
-
Enteral arginine does not increase superior mesenteric arterial blood flow but induces mucosal growth in neonatal pigs. J Nutr. 2011 Jan; 141(1):63-70.
-
Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci U S A. 2008 Dec 02; 105(48):18924-9.
-
Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J Vasc Res. 2009; 46(3):229-39.